MNI: PBOC Net Drains CNY142 Bln via OMO Thursday

MNI: PBOC Sets Yuan Parity Higher At 7.0742 Thurs; +3.18% Y/Y

CHINA PBOC CONDUCTS CNY150 BLN VIA 7-DAY REVERSE REPOS THURS

CHINA SETS YUAN CENTRAL PARITY AT 7.0742 THURS VS 7.0568

MNI BRIEF: Mexico Inflation Falls To 4.58% In September

MNI BRIEF: MNI BRIEF: Brazil's September Inflation Up To 4.42%

MNI: JAPAN SEPT CORP GOODS PRICE INDEX +2.8% Y/Y; AUG REV +2.6%

EZ/UK Bond Supply Calendar: BTP Auction on Friday

US EIA: CRUDE OIL STOCKS EX SPR +5.81M TO 422.7M OCT 04 WK

CANADA: Politics Week: Parliament Opens With Early Election Threats

AUSTRALIA: Albanese Lines Up Budget for May Election

AUSTRALIA: Albanese Lines Up Budget for May Election

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Walgreens Boots (WBA; B1, BB Neg) Asset sales continue

CONSUMER STAPLES
Credit BulletsBulletHomepagemarkets-real-timeCredit

  • Confirms it is considering sale or restructuring options on its stake in VillageMD (sits under loss-making US Healthcare segment). This isn't really news (was hinted at in earnings).
  • It has also disclosed it lent VillageMD a $1.75b secured term loan and $500m credit facility both in Jan 2023 and says defaults under the secured loan have occurred last week. It has entered into a forbearance agreement subject to VillageMD's compliance with certain conditions - which it hasn't disclosed.
  • Reminder it took a chunky $13.1b impairment charge on VillageMD earlier this year. It contributed $1.6b (+7%yoy) towards US Healthcare's $2.1b in revenues last qt, mgmt adding the co was on track to profitability. US Healthcare had a adj. -$22m loss last qtr and -$151m YTD (adj. excludes $13b impairment charge among other things).
  • Unclear who is lining up to buy this - i.e. not similar to its (liquid) stake in {COR US Equity} which it continues selling down (another $1.1b last week) to raise cash for BS. Still has 10%/circa $5b of firepower there.

Presser here

175 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

  • Confirms it is considering sale or restructuring options on its stake in VillageMD (sits under loss-making US Healthcare segment). This isn't really news (was hinted at in earnings).
  • It has also disclosed it lent VillageMD a $1.75b secured term loan and $500m credit facility both in Jan 2023 and says defaults under the secured loan have occurred last week. It has entered into a forbearance agreement subject to VillageMD's compliance with certain conditions - which it hasn't disclosed.
  • Reminder it took a chunky $13.1b impairment charge on VillageMD earlier this year. It contributed $1.6b (+7%yoy) towards US Healthcare's $2.1b in revenues last qt, mgmt adding the co was on track to profitability. US Healthcare had a adj. -$22m loss last qtr and -$151m YTD (adj. excludes $13b impairment charge among other things).
  • Unclear who is lining up to buy this - i.e. not similar to its (liquid) stake in {COR US Equity} which it continues selling down (another $1.1b last week) to raise cash for BS. Still has 10%/circa $5b of firepower there.

Presser here